Intuitive Surgical, Inc. ISRG
- Market cap
- $140.7B
- P/E
- 45.8×
Follow ISRG
Intuitive Surgical, Inc. (ISRG) Price to free cash flow
As of 25 September 2026, Intuitive Surgical, Inc. (ISRG) trades at a price to free cash flow of 43.9×. Over the past ten years it has ranged from 23.3× (January 2017) to 418× (September 2024); the current reading is higher than 27% of that period. That is above the Medical Instruments & Supplies industry median of 25.7× and above the Healthcare sector median of 19.5×.
Price to free cash flow, daily
Annual
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 81.2× | (42.93%) |
| FY2024 | 142× | (8.30%) |
| FY2023 | 155× | 57.29% |
| FY2022 | 98.6× | 34.83% |
| FY2021 | 73.1× | (12.69%) |
| FY2020 | 83.7× | 43.95% |
| FY2019 | 58.2× | 4.94% |
| FY2018 | 55.4× | 26.08% |
| FY2017 | 44.0× | 84.81% |
| FY2016 | 23.8× | (14.84%) |
Quarterly
| Period | Price to free cash flow | Change |
|---|---|---|
| Jun 2026 | 43.1× | (24.15%) |
| Mar 2026 | 56.8× | (30.01%) |
| Dec 2025 | 81.2× | 15.58% |
| Sep 2025 | 70.2× | (28.12%) |
| 42 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| SOLV Solventum Corporation compare | n/m |
| MDLN Medline Inc. compare | 12.9× |
| BAX Baxter International Inc. compare | 14.8× |
| BDX Becton, Dickinson and Company compare | 15.8× |
| ALC Alcon compare | 19.7× |
| RMD ResMed Inc. compare | 19.9× |
| ISRG Intuitive Surgical, Inc. | 43.9× |
| WST West Pharmaceutical Services, Inc. compare | 60.6× |
| RGEN Repligen Corporation compare | 175× |
| Medical Instruments & Supplies industry median | 25.7× |
| Healthcare sector median | 19.5× |
| Market median | 14.0× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on ISRG
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement